Jennie Taylor

City College of San Francisco — United States

Medicine · Health Sciences

33h-index7.0kcitations242works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(150), Radiomics and Machine Learning in Medical Imaging(23), Cancer Genomics and Diagnostics(22), Cancer-related cognitive impairment studies(22), Cancer, Hypoxia, and Metabolism(20)

Publications241 total

Improving fatigue and neurocognitive impairment in progressive neurological disorders: a systematic and narrative review
Heliyon·2025Open Access
Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient community
Neuro-Oncology Practice·2025Open Access
CTNI-53. PATIENTS WITH ISOCITRATE DEHYDROGENASE-MUTANT GLIOMA TREATED WITH VORASIDENIB: UPDATED DATA FROM THE VORASIDENIB EXPANDED ACCESS PROGRAM
Neuro-Oncology·2025· 1 citedOpen Access
QOL-14. Milton Marks Neuro-Oncology Family Camp (MMFC): 10 years of community building and support for families with a parent diagnosed with brain cancer
Neuro-Oncology·2025Open Access
CNSC-98. SYNAPTIC REMODELING DRIVES IDH-MUTANT ASTROCYTOMA PROGRESSION AND EVOLUTION
Neuro-Oncology·2025
IMG-135. Relationship between cognitive performance and central executive network functional connectivity in lower grade glioma
Neuro-Oncology·2025Open Access
EPID-19. The International Low Grade Glioma Registry: Use of IDH-Inhibitors in the real-world
Neuro-Oncology·2025Open Access
INNV-06. Build it and they will come: Cognitive rehabilitation in primary brain tumor
Neuro-Oncology·2025Open Access
BIOM-99. IDENTIFY OLIGODENDROGLIOMA PATIENT SURVIVAL GROUPS BY RECURSIVE PARTITION ANALYSIS
Neuro-Oncology·2025Open Access
TIP-08. Trial in progress update: A phase 1/2 study of intracranial and intravenous multi-dosing of DB107-RRV (formerly Toca 511) and DB107-FC (5-fluorocytosine) in combination with radiation ± temozolomide (TMZ) in patients with newly diagnosed high-grade gliomas (HGGs)
Neuro-Oncology·2025Open Access
QOL-02. Tele-Cognitive rehabilitation for adult lower grade glioma: A prospective feasibility study
Neuro-Oncology·2025Open Access
JS09.5.A SPATIAL TRANSCRIPTOMIC AND ELECTRODIAGNOSTIC PROFILING REVEALS SYNAPTIC CONNECTIVITY IS A HALLMARK OF OLIGODENDROGLIOMA RECURRENCE AND MALIGNANT TRANSFORMATION
Neuro-Oncology·2025Open Access
P02.02.A IL6 UNDERLIES MICROENVIRONMENT IMMUNOSUPPRESSION AND RESISTANCE TO THERAPY IN GLIOBLASTOMA
Neuro-Oncology·2025Open Access
P15.04.B TELE-COGNITIVE REHABILITATION FOR ADULT LOWER GRADE GLIOMA: A PROSPECTIVE FEASIBILITY STUDY
Neuro-Oncology·2025Open Access
Understanding and imaging PHGDH-driven intrinsic resistance to mutant IDH inhibition in gliomas
2025Open Access
Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study
Neuro-Oncology Practice·2025Open Access
Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative
Neuro-Oncology·2025Open Access
Spatial synaptic connectivity underlies oligodendroglioma evolution and recurrence
2025· 1 citedOpen Access
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma
2025· 3 citedOpen Access
Glioma mutational signatures associated with haloalkane exposure are enriched in firefighters
Cancer·2025· 1 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Jennifer Clarke(25), Nicholas Butowski(20), Susan M. Chang(19), Mitchel S. Berger(19), Annette M. Molinaro(18), Joanna J. Phillips(15), Nancy Ann Oberheim Bush(13), Shawn L. Hervey‐Jumper(10), David A. Solomon(10), Manish K. Aghi(9), Arie Perry(9), Michael D. Prados(8), Philip V. Theodosopoulos(8), Melike Pekmezci(8), Patrick Y. Wen(7), Andrew W. Bollen(7), John K. Wiencke(6), Margaret Wrensch(6), Anny Shai(6), Ingo K. Mellinghoff(6)